Retatrutide / Tirzepatide (combo)

This combination brings together two of the most-studied molecules in incretin pharmacology. Tirzepatide engages both the GIP and GLP-1 receptors; retatrutide adds glucagon receptor activity. All three are class B G-protein-coupled receptors that raise intracellular cyclic AMP. Co-engaging them produces signalling profiles that a single-target molecule can't, which is the whole rationale behind multi-agonist design.

This research-material blend combines two incretin-class research peptides to support laboratory investigation of multi-receptor metabolic signaling. It is referenced in controlled research models examining how distinct receptor pathways interact within nutrient-sensing and energy-regulation systems. Researchers may evaluate the components individually or collectively to study pathway synergy, signaling coordination, and broader metabolic-response mechanisms within controlled laboratory environments. Each batch is supported by accompanying documentation.

Strictly for in-vitro, cell-based, and preclinical laboratory research applications. No therapeutic, diagnostic, or clinical claims are made or implied.

• Multi-Incretin Signaling Studies — Investigation of coordinated GLP-1, GIP, and glucagon-associated receptor signaling within controlled metabolic research models.
• Energy-Regulation Research — Experimental study of energy-balance, nutrient-sensing, and metabolic-efficiency pathways in preclinical systems.
• Pathway-Synergy Analysis — Evaluation of additive or synergistic receptor interactions compared with single-target laboratory models.

What is Retatrutide / Tirzepatide (combo) used for?
This combination is a research-material blend made available exclusively to qualified researchers and laboratories for studies of multi-incretin receptor signaling and metabolic-pathway coordination. It is not intended for human or veterinary use, therapeutic application, or diagnostic purposes.

Who is eligible to purchase Retatrutide / Tirzepatide (combo)?
Retatrutide / Tirzepatide (combo) is sold exclusively to qualified researchers and licensed laboratories. By purchasing, buyers confirm they are knowledgeable in handling research-use-only (RUO) materials and will use the product in compliance with applicable regulations.

Is Retatrutide / Tirzepatide (combo) approved for human or veterinary use?
No. This product is supplied strictly as a research material and is not approved for human or veterinary use, ingestion, diagnosis, or treatment of any condition.

What purity and quality standards are used?
Each batch is manufactured to high-purity standards and undergoes analytical verification and quality-control review. A batch-specific Certificate of Analysis (COA) is provided to document identity, purity, and applicable testing.

How should Retatrutide / Tirzepatide (combo) be stored and handled?
It should be stored under controlled laboratory conditions, protected from heat, moisture, and direct light, and handled following standard laboratory protocols for research materials. Where applicable, avoid repeated freeze-thaw cycles.

Why does the vial appear nearly empty?
Research materials are supplied by analytical mass rather than visible volume. Contents may appear minimal within the container while still meeting the labeled specifications. This is normal for high-purity research materials.

Is documentation provided with each order?
Yes. Each batch is accompanied by a batch-specific Certificate of Analysis (COA) and supporting documentation to support quality assurance, batch traceability, and recordkeeping.

Can Retatrutide / Tirzepatide (combo) be used in combination studies?
In laboratory settings, Retatrutide / Tirzepatide (combo) may be evaluated alongside other research materials as part of structured experimental study designs. Any combination research should be conducted under controlled laboratory conditions and established analytical research protocols.

For laboratory and research use only. Not for human or veterinary use or consumption. Sold only to qualified researchers.

A Certificate of Analysis is issued for every lot and matched to the lot number printed on your vial. Identity is confirmed by mass spectrometry and purity by HPLC, with third-party ISO-accredited verification available on request. A Safety Data Sheet (SDS) is available for every product.

Orders are processed and shipped promptly via tracked courier. Materials ship lyophilized and remain stable in transit; on arrival, store as indicated on the vial — typically refrigerated or frozen and protected from light — for maximum stability.

See our Shipping & Returns policy for full details.